Back to Subject Index | Return to Arthritis & Rheumatism Table of Contents Page
- Decorin, in cultured human chondrocytes, 274
- DEK oncoprotein autoantibodies, with sarcoidosis and SLE, 1505
- Depression
- in RA, and age, 298
- in RA, long-term risk for pain, fatigue, disability, and, 1851
- Dexamethasone, effect on COX-2 and PGE2, 130
- Diarrhea, Clostridium difficile-associated, in RA, 2083
- Diclofenac, VLA/VCAM-1-mediated lymphocyte cell adhesion and, 1677
- 1,25-dihydroxyvitamin D (1,25(OH)2D3), in OA, 891
- Dimethylheptyl-THC-11 oic acid (DMH-11C), antiinflammatory activity of, 163
- Disability, in RA, long-term risk for depression, fatigue, pain, and, 1851
- Disease activity score (DAS versus DAS28), in SLE, 940
- Disease-modifying antirheumatic drugs (DMARDs), and clinical and radiologic outcomes in RA, 1190
- D-penicillamine, in SSc renal crisis, 1613
- Dysautonomia, in fibromyalgia, 1966
- Dysphoria, and long-term risk for pain, fatigue, and disability in RA, 1851
E
- EBNA-1, in RA, 92
- E-cadherin, αEβ7 interaction with, in SLE, 1456
- Eicosanoids, chondrocyte formation of, 1645
- Endothelial cells
- adhesion molecules and, 1677
- antiphospholipid antibodies and, 1738
- in Churg-Strauss syndrome, 445
- in rheumatoid synovitis, 1365
- Endothelin 1 (ET-1), in antiphospholipid syndrome, 800
- Environmental factors in the development of SLE, 1714
- Env/Tax proteins, autoantigens of, in human T cell leukemia virus type I, 101
- Enzyme-linked immunosorbent assay, for autoantibodies to ribosomal P peptides, 1137, 1138
- Eosinophil cationic protein (ECP), in Churg-Strauss syndrome, 445
- Epidemiology of SLE, in African-origin populations, 2091
- Epitopes
- aggrecan, in polyarteritis, 1007
- in collagen-induced arthritis, 507
- FVDIPEN, in collagen-induced arthritis and cartilage destruction, 110
- interleukin-1 regulation of matrix metalloproteinase-induced neoepitopes in antigen-induced arthritis, 647
- in SLE, 215
- Epstein-Barr virus (EBV), large-vessel arteritis associated with chronic active, 369
- Estrogen replacement therapy (ERT), and knee OA, 1867
- Exercise, and prevention of cartilage degeneration, 2068
- Exocrine glands and mucosal immunity, in rheumatic diseases, 572




